Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

People often let conditions such as high blood pressure and diabetes go for a long time without treatment. Here’s why you ...

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...

Drugs like Ozempic and Wegovy are now costing Connecticut taxpayers about $60 million this year and that figure could rise ...

The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

Type 2 diabetes is common; it affects one in ten adults internationally and one in five adults aged 65 years or older. It is ...

Eli Lilly forecast sales of popular weight-loss drug Zepbound and related diabetes treatment Mounjaro to miss Wall Street ...

In Tuesday's issue of The Lancet Diabetes & Endocrinology, dozens of international medical experts and people with lived ...

The federal health insurance program has selected 15 additional drugs covered by Medicare Part D for its next round of price ...